PTC299 Completed Phase 1 Trials for Brain and Central Nervous System Tumors Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 1 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT01158300 | PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors |